Therapeutic Asset Ratings
132 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
xl495
Metastatic Solid Tumor
Exelixis
P1
C
(37)
xt-0528
Metastatic Solid Tumor
Xenthera, Inc.
P1
C
(37)
ze94-0605
Metastatic Solid Tumor
Eilean Therapeutics
P1
C
(37)
mpt0b640
Metastatic Solid Tumor
J Ints Bio
Early P1
C
(34)
n-803
Metastatic Solid Tumor
ImmunityBio, Inc.
P1
C
(33)
Denosumab
Metastatic Solid Tumor
Second Affiliated Hospital of Soochow University
D
(28)
Bbp-398
Metastatic Solid Tumor
Navire Pharma Inc., a BridgeBio company
P1
D
(22)
Showing 126 to 132 of 132 assets
Previous
Page 6 of 6
Next